TFPI and neoplasm: In addition, another method was found by Gamperl in 2016, which was a low-molecular weight heparin called Tinzaparin that can induce the release of the tissue factor pathway inhibitor (TFPI) from tumor cells, and the recombinant TFPI then inhibits the TEXs inducing tumor cell migration [101].